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Cox-2 and osteopontin in cocultured platelets and mesangial Renal glomerular inflammation is characterized by in-
cells: Role of glucocorticoids. filtration of bone marrow-derived cells, platelets, granu-
Background. Glomerular inflammation is characterized by locytes, monocytic cells, and lymphocytes [1]. Regarding
a consecutive infiltration of immunoreactive cells. To mimic
the temporal relationship, platelets are among the firstthe early phase of glomerular injury, a coculture system of
cells to infiltrate the kidney transiently, as shown in dif-platelets and rat renal mesangial cells was established. As pro-
totypes, the inflammation-related proteins cyclooxygenase-2 ferent animal models, such as Habu snake venom-induced
(Cox-2) and the chemotactic protein osteopontin (OPN) were proliferative glomerulonephritis [2], experimental dia-
investigated. betic nephropathy [3], or immune complex nephritis [4, 5].
Methods. The expression of OPN and Cox-2 mRNA and pro-
Glomerular endothelial lesions caused by radiation ther-tein was determined by Northern and Western blot analyses.
apy also led to an influx of platelets into the mesangialResults. Coincubation of platelets and mesangial cells led to
space, allowing interaction with mesangial cells [6]. Thea rapid, transient induction of Cox-2 mRNA, which peaked at two
hours, whereas OPN and monocyte chemoattractant protein-1 functional importance of platelet infiltration was shown
(MCP-1) were induced at later time points. The induction of by treating animals with antiplatelet antibodies. Amelio-
Cox-2 mRNA was concentration dependent and highly repro- ration of renal function and reduced glomerular cell pro-
ducible when platelets of different donors were investigated.
liferation was observed in immune complex nephritis [4]Partial Cox-2 induction was observed when supernatants of
and the model of diabetic nephropathy [3]. Depletionpreactivated platelets were incubated with mesangial cells. The
of platelets also affected mediator release in acute neph-inhibition of the signaling pathways of platelet-derived growth
factor (PDGF) and epidermal growth factor (EGF) or interfer- rotoxic serum nephritis in rats [7]. Enhanced synthesis
ence with Gi-protein signaling partially inhibited platelet-induced of different types of eicosanoids, prostanoids and leuko-
Cox-2 expression. Down-regulation of protein kinase C (PKC), trienes, has been shown to be associated with immune-which is a common signaling module in many pathways leading to
mediated glomerular inflammation, with mesangial cellsCox-2 induction, almost completely abrogated platelet-induced
being the major source of glomerular prostaglandins [8].Cox-2 expression. The time pattern of Cox-2 and OPN expres-
sion suggested that Cox-2 might play a role in OPN induction. Regulation of prostaglandin synthesis in mesangial
The up-regulation of OPN was dependent on de novo protein cells has been studied in detail in vitro. Multiple stimuli,
synthesis and was induced by high levels of exogenous prosta- which are potentially released by platelets, are capable
glandin E2 (PGE2; 10 mmol/L). Endogenous PGE2, however, of inducing cyclooxygenase-2 (Cox-2), the inducible Coxproved not to be essential for OPN mRNA expression, because
isoform, among them platelet-derived growth factorinhibition of Cox activity did not change OPN mRNA levels.
(PDGF) [9], lysophosphatidic acid (LPA) [10], throm-Dexamethasone inhibited Cox-2 mRNA induction but increased
OPN mRNA and protein expression. boxane, or serotonin (5-HT) [11]. Other platelet-derived
Conclusion. These data indicate that Cox-2 and OPN are mediators, however, do not induce Cox-2 expression
independently up-regulated upon interaction of platelets and such as adenosine 59-triphosphate (ATP), but rather in-
mesangial cells.
hibit the induction of the enzyme by other stimuli [11].
The elevation of intracellular cAMP led to a complete
inhibition of 5-HT–mediated Cox-2 induction [12], sug-Key words: mesangial cells, platelets, cyclooxygenase, osteopontin, glu-
cocorticoids, injury. gesting that prostaglandin E2 (PGE2) itself might func-
tion as a negative regulator by binding to EP4 receptors,Received for publication June 28, 1999
which activate adenylate cyclase [13]. Platelets also re-and in revised form November 23, 1999
Accepted for publication January 4, 2000 lease factors such as platelet factor 4 (PF4), which in
vitro is able to inhibit mesangial cell proliferation [14].Ó 2000 by the International Society of Nephrology
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This suggests an antiproliferative rather than prolifera- cells/10 mL) were plated in 10 cm diameter Petri dishes
in medium with 10% (vol/vol) FCS. At subconfluencytive effect of platelets on glomerular mesangial cells.
Caution is thus needed to extrapolate from in vitro ex- (after 3 to 5 days), cells were growth arrested by serum
deprivation in DMEM containing 0.5% (vol/vol) FCSperiments using single stimuli to the in vivo situation, in
which multiple mediators act in concert and may exert for three to four days. Growth-arrested mesangial cells
were used in all experiments.synergistic as well as antagonistic effects. To mimic the
in vivo situation more closely, we established a coculture
Coincubation of mesangial cells and plateletssystem consisting of platelets and mesangial cells to inves-
tigate the regulation of Cox-2, a key enzyme of prostanoid Platelets were prepared from venous blood of healthy
human donors. For control experiments, platelets weresynthesis.
The early infiltration of platelets is followed by infil- also prepared from the blood of male Sprague-Dawley
rats. Platelet-rich plasma was obtained by centrifugationtration of other cells of the immune system, monocytic
cells, or lymphocytes. Activated mesangial cells may en- of citrate blood (190 3 g, 15 min at room temperature).
Platelets were counted, and an appropriate amount offorce this process by secreting chemoattractants such as
monocyte chemoattractant protein-1 (MCP-1) [15] or platelet-rich plasma containing the platelets needed to
stimulate one Petri dish of serum-deprived mesangialosteopontin (OPN) [16]. OPN is an acidic glycoprotein
with cell adhesive and chemotactic properties [17]. In cells (about 106 mesangial cells) was pelleted (2500 3 g,
48C, 15 min). The cells were resuspended in 50 mL me-the kidney, OPN has been implicated in macrophage
and lymphocyte recruitment to sites of inflammation in dium and were immediately transferred to the mesangial
cell culture dish.experimental models of glomerular and interstitial ne-
phritis [18–20]. In vitro, the up-regulation of OPN has
Northern blot analysisbeen observed in mesangial cells treated with fetal calf
serum (FCS) [16], but also with PDGF or LPA. This After stimulation for the times indicated, cells were
scraped with a rubber policeman into chilled 50 mL poly-suggested that platelets might be able to induce chemo-
tactic factors such as MCP-1 or OPN to regulate the propylene tubes and centrifuged (225 3 g, 48C). The
pellet was lyzed by adding 300 mL guanidinium isothiocy-subsequent infiltration of other cells of the immune sys-
tem. To test this hypothesis, the expression of MCP-1 anate-containing lysis solution. Total RNA was extracted
according to the protocol of Chomczynski and Sacchiand OPN was investigated in the coculture system of
platelets and mesangial cells. with minor alterations [22]. RNA yield usually was 30
to 40 mg/10 cm diameter Petri dish. Separation of total
RNA (10 mg/lane) was achieved by the use of 1.2%
METHODS
agarose gels containing 1.9% (vol/vol) formaldehyde
Materials with 1 3 MOPS as gel running buffer. Separated RNA
was transferred to nylon membranes by capillary blottingThe tyrphostins AG1296 and AG1478 were obtained
from Calbiochem (Bad Soden, Germany). 12-O-tetradeca- and fixed by baking at 808C for two hours.
Hybridization was performed with cDNA probes la-noylphorbol-13-acetate (TPA) was from Serva (Heidel-
berg, Germany). Stock solutions of AG1296, AG1478, beled with [32P]-dCTP using the Nonaprimer Labeling
Kit II (Oncor Appligene, Heidelberg, Germany) as de-and TPA were prepared in dimethyl sulfoxide (DMSO).
Therefore, respective concentrations of DMSO were in- scribed [23]. The specific Cox-1 and Cox-2 probes were
2.767 and 1.156 kb EcoRI fragments from the 59-end ofcluded in the medium of control incubations. Pertussis
toxin (PTX) was from Biomol (Hamburg, Germany). mouse cDNA, respectively [24]. A cDNA probe specific
for rat MCP-1 was kindly provided by Dr. T. YoshimuraCell culture reagents were from Biochrom (Berlin, Ger-
many). FCS was from GIBCO (Eggenstein, Germany). (NCI, Frederick, MD, USA) [15, 25]. The cDNA probe
specific for OPN was obtained as described previouslyTranswell plates (0.4 mm diameter) were obtained from
Costar (Cambridge, MA, USA). [26]. The GAPDH probe was obtained with a 500 bp
reverse-transcribed fragment [11]. Hybridization was
Cell culture performed by standard procedures [10]. DNA/RNA hy-
brids were detected by autoradiography using KodakRat mesangial cells were isolated and cultured as de-
scribed [21]. Cells were grown in Dulbecco’s modified X-OMAT AR film (Eastman Kodak, Rochester, NY,
USA).Eagle’s medium (DMEM) supplemented with 2 mmol/L
l-glutamine, 5 mg/mL insulin, 4.5 g/L glucose, 100 U/mL Quantitative analysis was performed by densitometric
scanning of the autoradiographs (Froebel, Wasserburg,penicillin, and 100 mg/mL streptomycin containing 10%
(vol/vol) FCS. Mesangial cells were used between pas- Germany). All values were corrected for differences in
RNA loading by calculating the ratio of Cox-2 or OPNsages 12 and 20.
For the experiments, renal mesangial cells (0.5 3 106 to GAPDH or 18S rRNA expression.
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Western blot analysis
Cellular proteins were isolated using RIPA buffer 850
mmol/L Tris/HCl, pH 7.5, 1% (vol/vol) Triton X100,
0.1% (wt/vol) deoxycholic acid, 0.1% (wt/vol) sodium
dodecyl sulfate (SDS), 150 mmol/L NaCl, 1 mmol/L phe-
nylmethylsulfonyl fluoride, 1 mmol/L sodium vanadate,
10 mmol/L sodium fluoride, and 3 mg/mL aprotinin. The
protein content of cellular lysates was determined with
the bicinchoninic acid protein assay (Pierce, Rockford,
IL, USA). OPN protein was detected in the cellular super-
natants of cells stimulated in serum-free medium. Super-
natants (2 mL) were concentrated by Nanosep columns
(Pall Filtron, Dreieich, Germany) to about 30 mL. The
concentrates were used in total for Western blot analysis.
Fig. 1. Platelet-induced proliferation of mesangial cells. MesangialFor Western blot analysis, 30 to 50 mg protein were
cells were incubated with different concentrations of platelets for 24separated by sodium dodecyl sulfate-polyacrylamide hours. Thymidine incorporation was determined over the last four hours
gel electrophoresis (SDS-PAGE; 10% polyacrylamide), of the incubation time. Data are mean 6 SD of triplicates of a typical
experiment.transferred onto polyvinylidene difluoride (PVDF) mem-
brane, and probed with a specific antibody directed
against Cox-2 (Cayman Chemical, Ann Arbor, MI, USA).
The antibody directed against rat OPN was kindly pro-
cells. Platelets sedimented and adhered to the mesangialvided by A. Beshensky (Veterans Affairs Medical Cen-
cells. As a functional aspect of platelet–mesangial cellter, Milwaukee, WI, USA). The peroxidase-conjugated
interaction, the effect of platelets on mesangial cell pro-antirabbit secondary antibody was obtained from Amer-
liferation was determined by measuring the incorpora-sham (Braunschweig, Germany). Protein-antibody com-
tion of radioactive thymidine. Thymidine incorporationplexes were visualized by the enhanced chemilumines-
was enhanced by increasing numbers of platelets (Fig. 1).cence detection system (ECL or ECL plus; Amersham).
The induction of proliferation was concentration depen-
Determination of PGE2 dent and plateaued at a concentration of 20 3 106/mL
platelets.Prostaglandin E2 was detected in cell culture superna-
tants by a specific enzyme-linked immunosorbent assay
Induction of gene expression by platelet-mesangial(ELISA) as described previously [27, 28].
cell coincubation
DNA synthesis
Coincubation of mesangial cells (about 106 cells per
For the determination of [3H]thymidine uptake, mes- dish) and platelets (5 3 107 platelets corresponding to
angial cells were serum deprived for two days in serum- 5 3 106/mL) induced the expression of the mRNA of
free DMEM medium. Cells were then stimulated for proteins related to inflammation (Fig. 2A). Cox-2 mRNA
24 hours. [3H]thymidine (2 mCi/mL; 2 Ci/mmol; ICN was up-regulated within the first hour, whereas up-regu-
Meckenheim, Germany) was added for the last four lation of the mRNAs of the chemotactic proteins OPN
hours of the incubation time. Then the cells were washed
and MCP-1 followed later. Gene induction was also ob-
with PBS, treated with 0.05/0.02% (wt/vol) trypsin/ethyl-
served when rat mesangial cells were incubated with ratenediaminetetraacetic acid (EDTA), and harvested by
platelets (Fig. 2B), excluding an effect caused by surfacea cell harvester. The incorporation of [3H]thymidine was
histocompatibility reactants.quantitated by liquid scintillation counting.
As a control, mesangial cells were incubated with vari-
ous amounts of platelet-poor plasma that might have
RESULTS remained in the platelet preparation. No effect on
mRNA expression was observed with up to 10 mL plate-Induction of mesangial cells proliferation by platelets
let poor plasma (data not shown). Platelets did not con-Platelets were prepared from the blood of healthy
tain detectable amounts of Cox-2 or OPN mRNA: RNAdonors and were kept as platelet-rich plasma until imme-
was extracted from 20 and 200 times higher numbers ofdiately before the start of the experiment in order to
platelets than those used in the coculture experiments,avoid activation of the platelets and release of soluble
but no Cox-2 or OPN signal was visible even after longermediators. The cells were then spun down and trans-
ferred without delay to the serum-deprived mesangial exposure times (Fig. 2C).
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Characterization of platelet-induced Cox-2
mRNA expression
We concentrated on the expression of Cox-2 as a very
early parameter of platelet–mesangial cell interaction.
The induction of Cox-2 was transient with maximal ex-
pression of Cox-2 mRNA after two hours (Fig. 3A). The
induction was dependent on the number of platelets (Fig.
3B). A linear correlation was obtained between 0.1 and
20 3 106 platelets per mesangial cell dish, corresponding
to 0.1 to 2 3 106 platelets per mL medium (Fig. 3C). The
incubation of mesangial cells with platelets had no effect
on the expression of Cox-1 mRNA. Platelets obtained
from different donors were compared in parallel to assess
donor variability. The capacity of platelets to induce
Cox-2 mRNA was found to be rather similar (Fig. 4).
In none of the experiments performed throughout the
study were platelets unable to induce Cox-2 mRNA.
Role of soluble mediators in platelet–mesangial
cell interactions
To assess the effect of soluble mediators released by
platelets, 2 3 107 platelets were incubated for 30 minutes
as platelet-rich plasma or in cell culture medium with
0.5% FCS. To stimulate the platelets, 1 mmol/L adeno-
sine diphosphate (ADP) was added. ADP was chosen
as activator because by itself it did not induce Cox-2
mRNA expression in mesangial cells (data not shown).
The effect of cell-free platelet supernatants obtained at
the end of the incubation period was compared with the
effect of platelets coincubated with mesangial cells. As
can be seen from Table 1, the induction of Cox-2 mRNA
was significantly reduced when only the soluble media-
tors were transferred. The activation of the platelets in
medium was more effective than in plasma.
To further support the importance of direct cell to cell
contact, experiments were performed in which platelets
were seeded in the upper part of transwell plates, which
allowed interaction via soluble mediators but prevented
direct contact between platelets and mesangial cells.
Compared with the direct interaction, the stimulation of
Cox-2 was reduced by 50%, comparable to the effects
observed with soluble mediators (data not shown).Fig. 2. Time-dependent increase in mRNA expression of inflammation-
related proteins. (A) Mesangial cells were incubated with FCS (F; 10%)
for two hours or with 5 3 106 human platelets/mL for the times indicated. Characterization of mediators involved in
Control cells (Co) were left untreated. mRNA was isolated as described platelet-induced Cox-2 mRNA expression
in the Methods section. The Northern blot was probed with cDNAs
specific for Cox-2, OPN, MCP-1, and GAPDH. (B) Rat mesangial cells To define mediators involved in platelet-induced Cox-2
were incubated with different concentrations of rat platelets for two and expression, the signaling pathways of the growth factors
six hours. Control cells (Co) were left untreated. The Northern blot was
PDGF and epidermal growth factor (EGF) were blockedprobed with cDNAs specific for Cox-2 and OPN. Ribosomal RNA (18S
rRNA) was stained with methylene blue to confirm equal loading. (C) by specific inhibitors tyrphostins AG1296 and AG1478,
RNA was extracted from 20 and 200 times higher numbers of human respectively [29]. Furthermore, mesangial cells were pre-platelets than those used in the coculture experiment (1 PL), where
incubated with PTX to interfere with mediators such asmesangial cells were cocultured for two and six hours.
LPA, which induce Cox-2 by binding to receptors that
couple to Gi proteins [10]. Inhibition of each pathway
led to a partial inhibition of Cox-2 induction (AG1296,
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Fig. 3. Characterization of Cox-2 mRNA induction by platelets. (A)
Mesangial cells were incubated with 2 3 106 platelets/mL for the times
indicated. Cox-2 expression was detected by Northern blot analysis.
Cox-2 mRNA was quantitated by densitometry and corrected for equal
loading using GAPDH expression as a reference. To compare different
experiments, stimulation after two hours was set to 100% (N 5 3,
6 means SD). (B) Mesangial cells were incubated with increasing num-
bers of platelets as indicated for two hours. As control, cells were left
untreated (Co) or incubated with 10% FCS (F). A typical Northern
blot was probed for Cox-2, Cox-1, and GAPDH. (C) Quantitative
determination of Cox-2 mRNA expression corrected by GAPDH ex-
pression. To compare different experiments, stimulation with 2 3 106
platelets/mL was set to 100% (N 5 3, mean 6 SD, one experiment
with 1 3 105 platelets/mL).
Fig. 4. Donor variability of Cox-2 mRNA ex-
pression. Platelets (PL; 20 and 5 3 105 cells/
mL) obtained from three different individuals
(Do1-3) were incubated with mesangial cells
for two hours. The Northern blot was probed
with cDNAs specific for Cox-2, Cox-1, and
GAPDH (inset). For the quantitative analysis,
Cox mRNA expression was corrected by
GAPDH expression.
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Table 1. Induction of Cox-2 mRNA by soluble previously to be independent of de novo protein synthe-
platelet-derived mediators
sis in mesangial cells [15]. In contrast, the preincubation
Cox-2 mRNA of mesangial cells with an inhibitor of translation, cyclo-
expression heximide, abrogated induction of OPN expression in the% 6 SD
coculture system (Fig. 7A). The different time pattern
Mesangial cells 5.561.3
of Cox-2 and OPN expression suggested that Cox-2 mightMesangial cells 1 platelets 100
Mesangial cells 1 platelet-conditioned plasma 20614 play a role in OPN induction. To test this hypothesis, mes-
Mesangial cells 1 platelet-conditioned medium 48612 angial cells were incubated with PGE2 (10 mmol/L), which
Platelets and mesangial cells were either cocultured or mesangial cells were resulted in the up-regulation of OPN mRNA (Fig. 7A).
incubated with supernatants of the same number of platelets obtained after a
PGE2 thus proved to be a potential mediator of OPN30-minute incubation period in plasma or cell culture medium in the presence
of 1 mmol/L ADP. Cox-2 mRNA expression obtained by coincubation of platelets induction. The role of endogenously generated PGE2
and mesangial cells was set to 100% (N 5 3, mean 6 SD).
was assessed by inhibiting Cox activity by the nonselec-
tive Cox inhibitor ibuprofen and by interference with
the induction of Cox-2 expression by the synthetic gluco-
corticoid dexamethasone. Both ibuprofen (10 mmol/L)16%; AG1478, 14%; PTX, 34%; means of 2 experiments;
Fig. 5A), indicating that not a single mediator but a and dexamethasone (1026 mol/L) inhibited PGE2 synthe-
sis in the coculture system of platelets and mesangialcombination of various mediators is responsible for the
observed effect on gene expression. In line with these cells (Fig. 7B). Dexamethasone reduced PGE2 to basal
levels, whereas ibuprofen affected basal as well as stimu-observations, a stronger inhibitory effect was observed
when protein kinase C (PKC) was down-regulated prior lated levels consistent with its inhibition of both Cox
isoforms. OPN mRNA induction, however, was not in-to incubation with platelets. PKC has been shown to be
an essential part of the intracellular signaling cascade hibited by either dexamethasone or ibuprofen (Fig. 7C).
Pretreatment of mesangial cells with ibuprofen did not af-of various stimuli leading to the induction of Cox-2 in
mesangial cells [9, 11, 12]. Overnight incubation of mes- fect the induction of OPN mRNA, whereas OPN mRNA
angial cells with phorbolester (TPA, 1027 mol/L) com- was further up-regulated by dexamethasone. Similarly,
pletely down-regulated PKC, as shown by the inability dexamethasone enhanced up-regulation of OPN by
of TPA to induce Cox-2 mRNA (Fig. 5B, gray bar com- PDGF (Fig. 8A). Even in the absence of additional stim-
pared with open bar). Pretreatment of mesangial cells uli, dexamethasone was able to induce a long-lasting
with TPA also prevented the subsequent induction of elevation of OPN mRNA (Fig. 8 A, B). OPN is a secreted
Cox-2 by coincubation with platelets, indicating that protein detectable in mesangial cell culture supernatants.
PKC activation is essential for the induction of Cox-2 Up-regulation of OPN mRNA by dexamethasone in-
mRNA expression by platelet products. creased OPN protein levels detected after 24 hours
(Fig. 8C).
Interference of dexamethasone with platelet-induced
Cox-2 synthesis
DISCUSSIONGlucocorticoids interfere with Cox-2 mRNA and/or
A role for platelets in modulating glomerular eicosa-protein expression, depending on the cell type and stimu-
noid metabolism during glomerular injury has beenlus used [30]. To investigate the effect on platelet-mesan-
shown in several experimental in vivo studies. To furthergial cell coincubation, mesangial cells were pretreated
characterize the interaction between platelets and resi-with different concentrations of dexamethasone and
dent glomerular cells, we used an in vitro coculture sys-then stimulated with platelets (Fig. 6). Cox-2 mRNA
tem and investigated the regulation of one of the keyinduction detected after two hours of incubation was
enzymes of prostanoid synthesis, the inducible Cox iso-inhibited in a concentration-dependent manner by dexa-
zyme (Cox-2). Regulation of this enzyme has been stud-methasone. Induced Cox-2 protein expression in mesan-
ied in detail in mesangial cells using individual stimuli.gial cells is stable over several hours and can easily be
This approach allows detailed elucidation of signalingdetected after five hours. At this time point, dexametha-
mechanisms but may obscure more complex regulationssone was found to interfere with Cox-2 protein expres-
effective in vivo when multiple stimuli, as well as directsion, although to a lesser extent than with mRNA synthesis.
cell to cell interactions, act in concert to modulate gene
Independent regulation of OPN and Cox-2: expression.
Up-regulation of OPN by dexamethasone Coincubation of freshly isolated platelets and serum-
deprived mesangial cells led to a rapid interaction of theCompared with the rapid induction of Cox-2 mRNA,
cells, resulting in the induction of gene expression in andelevated levels of the two chemotactic proteins, MCP-1
proliferation of the mesangial cells. Compared with otherand OPN, were observed only after four to six hours
(Fig. 2). The induction of MCP-1 mRNA has been shown coculture systems, the system platelet-mesangial cells
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Fig. 5. Signaling pathways involved in plate-
let-induced Cox-2 mRNA expression. (A)
Mesangial cells were pretreated with an inhib-
itor of PDGF receptor autophosphorylation
AG1296 (AG12, 10 mmol/L), an inhibitor of
EGF receptor autophosphorylation (AG1478,
AG14, 0.1 mmol/L) for 30 minutes, or PTX
(PT, 100 ng/mL) overnight and then incubated
with platelets (2 3 106 cells/mL) for two hours.
The blot is representative for two independent
experiments. (B) Mesangial cells were pre-
treated with TPA (1027 mol/L) for 20 hours
to down-regulate PKC. Untreated (h) and
TPA-treated ( ) mesangial cells were then
incubated with TPA (1027 mol/L) or 5 3 106
platelets/mL (PL) for two hours. Cox-2 mRNA
expression (inset, C) was corrected for GAPDH
(inset, G) expression. Data shown are repre-
sentative for two independent experiments.
was straight forward to interpret, as only one of the
cell types, the mesangial cells, is able to regulate gene
expression and to proliferate.
The kinetics of Cox-2 mRNA induction were compa-
rable to the rapid kinetics observed with stimuli such as
LPA, 5-HT, PDGF, or FCS, which also induce Cox-2
mRNA within one to two hours of stimulation. This is
in contrast to other types of stimuli such as interleukin-1
in mesangial cells [31] or lipopolysaccharide in macro-
phages [32], which take several hours to induce Cox-2
mRNA. The kinetics of Cox-2 induction are also depen-
dent on the cell type: In monocytic cells, membrane
microparticles shed from activated platelets have re-
cently been shown to induce a long-lasting increase of
Cox-2 mRNA expression [33]. With respect to time and
efficiency of induction, there was very little variability
between the platelets obtained from different donors.
In addition to secreting active mediators, platelets also
interact with other cells by direct cell–cell contact
through adhesion receptors. This type of interaction has
Fig. 6. Interference of dexamethasone with Cox-2 induction. Mesan- been studied in detail, focusing on the interaction of
gial cells were pretreated with different concentrations (1026 to 10210 platelets and leukocytes [34, 35], but also of plateletsmol/L) of dexamethasone for one hour and then were incubated with
and endothelial cells of the blood vessel wall [36, 37],5 3 106 platelets/mL for two hours for mRNA analysis and five hours
for protein analysis. Western blots were detected with an antibody endothelial injury being a prerequisite for platelets to
directed specifically against Cox-2. Northern blots were probed with a infiltrate sites of inflammation. To assess the importancerespective cDNA. Data shown are representative for three independent
experiments with similar results. of direct cell–cell interaction for the induction of Cox-2
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Fig. 7. Independent regulation of Cox-2 and OPN. (A) Mesangial cells
were stimulated with platelets (2 3 106 cells/mL) for five hours with or
without preincubation with cycloheximide (CHX; 10 mg/mL) for one Fig. 8. Induction of OPN by dexamethasone. (A) Mesangial cells were
hour. In addition, mesangial cells were stimulated with 10 mmol/L incubated with PDGF (20 ng/mL) and/or dexamethasone (1026 mol/L)
PGE2. Northern blot analysis was performed to detect OPN mRNA. for 24 hours. To compare the expression of OPN mRNA in four inde-
The blot is representative of three independent experiments. (B) Mesan- pendent experiments, expression of OPN in control cells was set to 1.
gial cells were preincubated with dexamethasone (Dex, 1026 mol/L) or Data are mean 6 SD. (B) Time course of OPN induction by dexametha-
ibuprofen (10 mmol/L) for one hour and then further incubated with sone (1026 mol/L). (C) OPN protein expression in mesangial cell culture
or without platelets for five hours. Supernatants were collected and supernatants stimulated with PDGF (P, 20 ng/mL) or dexamethasone
assayed for PGE2 by ELISA. Data are means of two experiments with (D, 1026 mol/L) for 24 hours.
duplicate determinations. (C) Mesangial cells were treated as described
in B. OPN mRNA expression was detected by Northern blot analysis.
The blot is representative of three independent experiments.
be bidirectional, that is, stimulate the platelets to release
soluble mediators or add to the activation of signaling
mRNA expression, platelets were preactivated and the pathways in mesangial cells.
cell-free supernatant transferred to mesangial cells, or In an attempt to characterize the contribution of indi-
platelets were coincubated with mesangial cells in trans- vidual mediators released by platelets, inhibitors were
well plates, which prevented direct cell–cell interaction. used to target specific signaling pathways. The autophos-
phorylation of the PDGF and the EGF receptor wasIn the absence of direct intercellular contact, the re-
sponse to the platelet-released mediators was signifi- inhibited by the tyrphostins AG1296 and AG1478, which
have been shown recently to effectively block the induc-cantly reduced, suggesting an enhancing effect by direct
cell contact possibly mediated by adhesion molecules tion of Cox-2 by these growth factors in mesangial cells
[29]. The contribution of activators of receptors coupledsuch as P-selectin. The direct cell–cell interaction might
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to Gi proteins, such as LPA, was assessed by pretreat- profen, a strong inhibitor of PGE2 synthesis by both Cox
isoforms, did not affect OPN expression. This suggestedment of the mesangial cells with PTX. Each of these
treatments led to a partial reduction of Cox-2 expression, that the local concentrations of PGE2 necessary to induce
OPN expression were not achieved in the coculture sys-showing the cooperative action of different mediators
in this model of cell–cell interaction. A much stronger tem. Independent regulation of OPN and Cox-2 was
shown with dexamethasone, which inhibited the expres-inhibitory effect was observed when activation of PKC
was prevented, which is one of the important intracellu- sion of Cox-2, but instead of interfering, dexamethasone
rather enhanced OPN expression. Induction of OPN bylar signaling molecules involved in different signaling
pathways originating from activation of receptors cou- dexamethasone has been described in osteoprogenitor
cells [38] and was related to the induction of an osteo-pled to G proteins [11, 12], or from tyrosine kinase recep-
tors [9]. The down-regulation of PKC by prolonged incu- blast-like phenotype. Regarding the proposed role of
OPN in attracting monocytes to the inflamed glomerulus,bation with phorbol ester strongly reduced induction of
Cox-2 by platelets, indicating a central role for PKC down-regulation rather than up-regulation of OPN by
dexamethasone had been expected. The role of OPN,that is not overcome by the multiple signaling pathways
probably activated by platelet products. however, may not be restricted to its chemoattractive
properties. In myocytes and microvascular endothelialGlucocorticoids inhibit prostaglandin synthesis pri-
marily by interfering with Cox-2 synthesis. Depending cells, increased OPN expression was related to the gluco-
corticoid-mediated suppression of nitric oxide synthaseon cell type and stimulus, different molecular levels are
targeted by glucocorticoids, protein synthesis, mRNA expression [39]. Thus, the functional consequences of
glucocorticoid-mediated interference with OPN expres-stability, or mRNA transcription of Cox-2 [30]. Pretreat-
ment of mesangial cells with different concentrations of sion in the glomerulus need further evaluation.
The coculture system of platelets and mesangial cellsdexamethasone led to a concentration-dependent reduc-
tion of Cox-2 mRNA expression, with concentrations of used in the present study thus allowed us to mimic early
events of glomerular inflammation. The rather small1029 mol/L dexamethasone still being effective. The ef-
fect on Cox-2 protein levels was less pronounced, but variability with platelets obtained from different donors
proved this system suitable for future characterizationstill significant at concentrations of 1027 mol/L dexa-
methasone. Interestingly, there was a tendency to in- of various aspects of platelet–mesangial cell interaction
relevant in the initial phase of glomerular injury.creased Cox-2 protein levels at lower concentrations of
dexamethasone. There are different possibilities to ex-
plain these apparent discrepancies between mRNA and ACKNOWLEDGMENTS
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